A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma.
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Montelukast (Primary) ; Salbutamol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck & Co
- 14 Apr 2010 Actual patient number changed from 64 to 68 as reported by ClinicalTrials.gov.
- 05 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jan 2009 Actual initiation date changed from Jun 2008 to Jul 2008 as reported by ClinicalTrials.gov.